About this trial
The relationship between RSV (human respiratory syncytial virus) infections and invasive infections or pneumonia caused by Streptococcus pneumoniae has been observed epidemiologically for several years. Few fundamental data exist to support the epidemiological relationship. This study will investigate the proportion of pneumococcal carriage in RSV-infected infants and noninfected infants (proportion, serotype profile).
Eligibility criteria
Qualifiers
Infants aged 6 months to 18 months inclusive
With bronchiolitis during RSV epidemic season (bronchiolitis group) or without evidence of RSV viral infection (healthy group)
No chronic illness
No history of bronchiolitis
Disqualifiers
Chronic respiratory illness
Medical history of bronchiolitis or newborn asthma
Treatment with immunosuppressants
Patient on AME
Trial design
Treatments tested in this trial
- Swab collection
Treatment groups
Sponsors and collaborators
Assistance Publique - Hôpitaux de Paris
Lead sponsor
National Pneumococcal Reference Center
Collaborator
Infectious Diseases Models for Innovative Therapies
Collaborator